TSX:WEED (Canopy Growth)
About WEED
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Canopy Growth (TSX: WEED) Latest News
Investing
Is Canopy Growth Corp. Stock an Opportunistic Buy on the Dip?
Investing
Canopy Growth Corp. vs. Aurora Cannabis Inc.: Which Marijuana Stock Is a Better Buy?
Investing
Why it’s Not Too Late to Put a Little Pot in Your Portfolio
Investing
Should Investors Be Excited Over the Prospect of Privatized Cannabis Retail in Ontario?
Investing
Are Cannabis Stocks Cheap After Dropping Heavily in Value?
Investing
2 Big Concerns for the Cannabis Industry That Could Derail its Growth
Investing
2 Important Questions Cannabis Investors Should Ask Before Buying Pot Stocks
Investing
Why This Pot Stock Could Be a Better Buy Than Canopy Growth Corp.
Investing
Which of These 2 Up-and-Coming Marijuana Companies Makes the Better Addition to Your Portfolio?